A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ABT-450, ritonavir and
ABT-267 (ABT-450/r/ABT-267; ABT-267 also known as ombitasvir) and ABT-333 (also known as
dasabuvir) co-administered with ribavirin (RBV) in hepatitis C virus genotype 1 infected
treatment-experienced adults.